News & HighlightsNews
New genomic approaches uncover surprising cellular dynamics of the aging brain
Two techniques—one for optics-free spatial mapping of tissue organization and the other for the enrichment of rare cell types—offer new ways to study aging and disease.
How basic biology helps build better vaccines 
A deep understanding of how immune cells respond to infection could revolutionize vaccine design.
Researchers track the mutations that allow HIV-1 to escape broadly neutralizing antibodies
Study shows the most comprehensive view to date of how some viral strains develop drug resistance.
A hidden inheritance could explain disease risks beyond DNA
Lamia Wahba is studying how information outside the genetic code can pass between generations and what that means for evolution and disease.
Researchers capture an unprecedented view of gene transcription
RNA polymerase, the enzyme that synthesizes RNA from DNA during transcription, has been captured mid-reaction for the first time. The findings provide a universal blueprint for gene expression.
For musically inclined scientists, similarities between music and science yield benefits for both
Rockefeller musicians find joy in performing, but also community and inspiration in the creative practice.
Vanessa Ruta and Thomas Tuschl are elected to the National Academy of Sciences
The two scientists are the 35th and 36th members of Rockefeller's current faculty to be honored with membership in the prestigious academy founded by Abraham Lincoln.
Rockefeller Outreach shares insights on how to keep young students in science
More than a decade of data from the university’s RockEDU programs shows that persistence in STEM is driven by the systems that support students.
How cells turn mechanical forces into biochemical signals
The findings, which have implications for cancer and other diseases, resulted from capturing the first snapshot of a mechanical signaling complex in action.
New clues to hepatitis B species restriction could help build a novel model for studying infection and testing therapies
The study overturns decades-long assumptions about why HBV fails to infect mouse liver cells, pointing towards a new disease model.
View
View